chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pyrexia, Vaccination site pain
Clinical narrative: fever; pain at  the injection site; fatigue; headache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), VACCINATION SITE PAIN (pain at  the injection site), FATIGUE (fatigue) and HEADACHE (headache) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 088D21A, 022M20A and 042L20A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy. Concomitant products included VALSARTAN, ATORVASTATIN, HYDROCHLOROTHIAZIDE, SILODOSIN, CALCIUM CARBONATE, COLECALCIFEROL (CALCIUM & VITAMIN D3), VITAMIN C [ASCORBIC ACID], ASCORBIC ACID, CALCIUM, MINERALS NOS, RETINOL, TOCOPHERYL ACETATE, VITAMIN B NOS, VITAMINS NOS, ZINC (CENTRUM SILVER [ASCORBIC ACID;CALCIUM;MINERALS NOS;RETINOL;TOCOPHERYL ACETATE;VITAMIN B NOS;VITAMINS NOS;ZINC]) and OMEPRAZOLE for an unknown indication.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Aug-2021, the patient experienced PYREXIA (fever), VACCINATION SITE PAIN (pain at  the injection site), FATIGUE (fatigue) and HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL 8 HR ARTHRITIS PAIN) for Adverse event, at a dose of 650 mg. On 18-Aug-2021, PYREXIA (fever), VACCINATION SITE PAIN (pain at  the injection site), FATIGUE (fatigue) and HEADACHE (headache) had resolved.            This case was linked to MOD-2021-308164, MOD-2021-308129 (Patient Link).
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Dyspnoea, Fatigue, Pain in extremity
Clinical narrative: sick to my stomach; out of breath; pain in arm; feeling very tired; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (sick to my stomach), DYSPNOEA (out of breath), PAIN IN EXTREMITY (pain in arm) and FATIGUE (feeling very tired) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0451B21A, 001B21A and 006M20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high and Kidney failure (stage 3 kidney failure).   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ABDOMINAL DISCOMFORT (sick to my stomach), DYSPNOEA (out of breath), PAIN IN EXTREMITY (pain in arm) and FATIGUE (feeling very tired). At the time of the report, ABDOMINAL DISCOMFORT (sick to my stomach), DYSPNOEA (out of breath), PAIN IN EXTREMITY (pain in arm) and FATIGUE (feeling very tired) outcome was unknown.            she was not authorized by her physician to get 3rd dose. she decided to get the dose on her own. she got the vaccine as she has high blood pressure and stage 3 kidney failure, Concomitant medications were not provided. Treatment information was not provided.   This case was linked to MOD-2021-308166 (Patient Link).
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Balance disorder, Diarrhoea, Headache, Lymphadenopathy
Clinical narrative: Problems with their balances; Bad lower back pain; Neck pain like their tendons feel swollen; Massive diarrhea; Some visual disturbers; Tickling of their right side  of their body; Headaches; Rush in their arm; Pain a cross their body; Swollen of the lymph nodes; Muscle  pain in the arm of the  injection; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Rush in their arm), BALANCE DISORDER (Problems with their balances), BACK PAIN (Bad lower back pain), NECK PAIN (Neck pain like their tendons feel swollen) and DIARRHOEA (Massive diarrhea) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 020f21a and 052e21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.    On 02-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 31-Aug-2021, the patient experienced PAIN IN EXTREMITY (Rush in their arm), MYALGIA (Pain a cross their body), LYMPHADENOPATHY (Swollen of the lymph nodes) and VACCINATION SITE PAIN (Muscle  pain in the arm of the  injection). On 02-Sep-2021, the patient experienced BALANCE DISORDER (Problems with their balances), BACK PAIN (Bad lower back pain), NECK PAIN (Neck pain like their tendons feel swollen), DIARRHOEA (Massive diarrhea), VISUAL IMPAIRMENT (Some visual disturbers), VACCINATION SITE PARAESTHESIA (Tickling of their right side  of their body) and HEADACHE (Headaches). The patient was treated with PARACETAMOL (TYLENOL) on 02-Sep-2021 for Adverse event, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Rush in their arm), BALANCE DISORDER (Problems with their balances), BACK PAIN (Bad lower back pain), NECK PAIN (Neck pain like their tendons feel swollen), DIARRHOEA (Massive diarrhea), VISUAL IMPAIRMENT (Some visual disturbers), VACCINATION SITE PARAESTHESIA (Tickling of their right side  of their body), MYALGIA (Pain a cross their body), LYMPHADENOPATHY (Swollen of the lymph nodes), VACCINATION SITE PAIN (Muscle  pain in the arm of the  injection) and HEADACHE (Headaches) outcome was unknown.            No concomitant medications were reported.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Neck pain, Pain in extremity, Vaccination site pain, Vaccination site paraesthesia
Clinical narrative: Problems with their balances; Bad lower back pain; Neck pain like their tendons feel swollen; Massive diarrhea; Some visual disturbers; Tickling of their right side  of their body; Headaches; Rush in their arm; Pain a cross their body; Swollen of the lymph nodes; Muscle  pain in the arm of the  injection; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Rush in their arm), BALANCE DISORDER (Problems with their balances), BACK PAIN (Bad lower back pain), NECK PAIN (Neck pain like their tendons feel swollen) and DIARRHOEA (Massive diarrhea) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 020f21a and 052e21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.    On 02-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 31-Aug-2021, the patient experienced PAIN IN EXTREMITY (Rush in their arm), MYALGIA (Pain a cross their body), LYMPHADENOPATHY (Swollen of the lymph nodes) and VACCINATION SITE PAIN (Muscle  pain in the arm of the  injection). On 02-Sep-2021, the patient experienced BALANCE DISORDER (Problems with their balances), BACK PAIN (Bad lower back pain), NECK PAIN (Neck pain like their tendons feel swollen), DIARRHOEA (Massive diarrhea), VISUAL IMPAIRMENT (Some visual disturbers), VACCINATION SITE PARAESTHESIA (Tickling of their right side  of their body) and HEADACHE (Headaches). The patient was treated with PARACETAMOL (TYLENOL) on 02-Sep-2021 for Adverse event, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Rush in their arm), BALANCE DISORDER (Problems with their balances), BACK PAIN (Bad lower back pain), NECK PAIN (Neck pain like their tendons feel swollen), DIARRHOEA (Massive diarrhea), VISUAL IMPAIRMENT (Some visual disturbers), VACCINATION SITE PARAESTHESIA (Tickling of their right side  of their body), MYALGIA (Pain a cross their body), LYMPHADENOPATHY (Swollen of the lymph nodes), VACCINATION SITE PAIN (Muscle  pain in the arm of the  injection) and HEADACHE (Headaches) outcome was unknown.            No concomitant medications were reported.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Visual impairment
Clinical narrative: Problems with their balances; Bad lower back pain; Neck pain like their tendons feel swollen; Massive diarrhea; Some visual disturbers; Tickling of their right side  of their body; Headaches; Rush in their arm; Pain a cross their body; Swollen of the lymph nodes; Muscle  pain in the arm of the  injection; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Rush in their arm), BALANCE DISORDER (Problems with their balances), BACK PAIN (Bad lower back pain), NECK PAIN (Neck pain like their tendons feel swollen) and DIARRHOEA (Massive diarrhea) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 020f21a and 052e21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.    On 02-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 31-Aug-2021, the patient experienced PAIN IN EXTREMITY (Rush in their arm), MYALGIA (Pain a cross their body), LYMPHADENOPATHY (Swollen of the lymph nodes) and VACCINATION SITE PAIN (Muscle  pain in the arm of the  injection). On 02-Sep-2021, the patient experienced BALANCE DISORDER (Problems with their balances), BACK PAIN (Bad lower back pain), NECK PAIN (Neck pain like their tendons feel swollen), DIARRHOEA (Massive diarrhea), VISUAL IMPAIRMENT (Some visual disturbers), VACCINATION SITE PARAESTHESIA (Tickling of their right side  of their body) and HEADACHE (Headaches). The patient was treated with PARACETAMOL (TYLENOL) on 02-Sep-2021 for Adverse event, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Rush in their arm), BALANCE DISORDER (Problems with their balances), BACK PAIN (Bad lower back pain), NECK PAIN (Neck pain like their tendons feel swollen), DIARRHOEA (Massive diarrhea), VISUAL IMPAIRMENT (Some visual disturbers), VACCINATION SITE PARAESTHESIA (Tickling of their right side  of their body), MYALGIA (Pain a cross their body), LYMPHADENOPATHY (Swollen of the lymph nodes), VACCINATION SITE PAIN (Muscle  pain in the arm of the  injection) and HEADACHE (Headaches) outcome was unknown.            No concomitant medications were reported.
Sex: M
Vaccine: COVID19
Symptoms: Headache, Nausea, Pain, Pyrexia
Clinical narrative: body ache; low grade temperature; nausea; headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body ache), PYREXIA (low grade temperature), NAUSEA (nausea) and HEADACHE (headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003F2121A, 003F2121A and 003F2121A) for COVID-19 vaccination.     Concurrent medical conditions included Immunocompromised.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 29-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 100 microgram. On 29-Aug-2021, the patient experienced PAIN (body ache), PYREXIA (low grade temperature), NAUSEA (nausea) and HEADACHE (headache). At the time of the report, PAIN (body ache), PYREXIA (low grade temperature), NAUSEA (nausea) and HEADACHE (headache) outcome was unknown.
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: mixed vaccine of Pfizer and Moderna was administered to a patient; This spontaneous case was reported by a pharmacist and describes the occurrence of OFF LABEL USE (mixed vaccine of Pfizer and Moderna was administered to a patient) in a 22-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Sep-2021, the patient experienced OFF LABEL USE (mixed vaccine of Pfizer and Moderna was administered to a patient). On 04-Sep-2021, OFF LABEL USE (mixed vaccine of Pfizer and Moderna was administered to a patient) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant product was provided by the reporter. No treatment medication was provided.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache
Clinical narrative: headache; generalized fatigue; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) and FATIGUE (generalized fatigue) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Cancer and Penicillin allergy. Concomitant products included DESVENLAFAXINE SUCCINATE MONOHYDRATE (PRISTIQ), BENAZEPRIL, METOPROLOL, OMEPRAZOLE (PRILOSEC [OMEPRAZOLE]), EMERGEN C and LORATADINE (CLARITINE) for an unknown indication.    On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Dec-2020, the patient experienced HEADACHE (headache) and FATIGUE (generalized fatigue). At the time of the report, HEADACHE (headache) and FATIGUE (generalized fatigue) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Treatment medication was not reported.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Malaise
Clinical narrative: Has not received the 2nd dose yet passed 40 day period, Positive for covid after the 1st dose; I was a little sick but i m fine now; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Has not received the 2nd dose yet passed 40 day period, Positive for covid after the 1st dose) and MALAISE (I was a little sick but i m fine now) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19.   On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Has not received the 2nd dose yet passed 40 day period, Positive for covid after the 1st dose) and MALAISE (I was a little sick but i m fine now). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Has not received the 2nd dose yet passed 40 day period, Positive for covid after the 1st dose) and MALAISE (I was a little sick but i m fine now) had resolved.            No concomitant medication reported. No treatment information was provided    This case was linked to MOD-2021-256441 (Patient Link).
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021C21A and 027B21A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Regulin) and Contrast media allergy.   On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIZZINESS (dizziness). At the time of the report, DIZZINESS (dizziness) had not resolved.            Patient visited the neurologist and underwent a cut scan, no abnormalities were found.  No concomitant medications were reported.  No treatment medications were reported.    This case was linked to MOD-2021-307813 (Patient Link).
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Acute disseminated encephalomyelitis, Back pain, Body temperature, Headache, Magnetic resonance imaging head
Clinical narrative: Acute disseminated encephalomyelitis; urinary retention; back pain; neck pain; headache; fever; nausea; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of ACUTE DISSEMINATED ENCEPHALOMYELITIS (Acute disseminated encephalomyelitis), URINARY RETENTION (urinary retention), BACK PAIN (back pain), NECK PAIN (neck pain), HEADACHE (headache), PYREXIA (fever), NAUSEA (nausea) and VOMITING (vomiting) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Atopic dermatitis, Depression, Upper respiratory infection and Diarrhea.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ACUTE DISSEMINATED ENCEPHALOMYELITIS (Acute disseminated encephalomyelitis) (seriousness criteria hospitalization and medically significant), URINARY RETENTION (urinary retention) (seriousness criteria hospitalization and medically significant), BACK PAIN (back pain) (seriousness criterion hospitalization), NECK PAIN (neck pain) (seriousness criterion hospitalization), HEADACHE (headache) (seriousness criterion hospitalization), PYREXIA (fever) (seriousness criterion hospitalization), NAUSEA (nausea) (seriousness criterion hospitalization) and VOMITING (vomiting) (seriousness criterion hospitalization). The patient was treated with METHYLPREDNISOLONE at an unspecified dose and frequency. At the time of the report, ACUTE DISSEMINATED ENCEPHALOMYELITIS (Acute disseminated encephalomyelitis), URINARY RETENTION (urinary retention), BACK PAIN (back pain), NECK PAIN (neck pain), HEADACHE (headache), PYREXIA (fever), NAUSEA (nausea) and VOMITING (vomiting) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: high (High) Fever 37.5 degree Celsius. On an unknown date, Magnetic resonance imaging head: abnormal (abnormal) Showed distinctive for ADEM wide spread demyelinating lesions. On an unknown date, Magnetic resonance imaging spinal: abnormal (abnormal) Showed distinctive for ADEM wide spread demyelinating lesions. On an unknown date, Neurological examination: abnormal (abnormal) showed Nuchal rigidity, bilateral Babinski signs with out neurological deficit symptoms.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medical information were reported. Company Comment : Very limited information regarding this event has been provided at this time. Further information has been requested.; Sender's Comments: Very limited information regarding this event has been provided at this time. Further information has been requested.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Magnetic resonance imaging spinal, Nausea, Neck pain, Neurological examination, Pyrexia
Clinical narrative: Acute disseminated encephalomyelitis; urinary retention; back pain; neck pain; headache; fever; nausea; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of ACUTE DISSEMINATED ENCEPHALOMYELITIS (Acute disseminated encephalomyelitis), URINARY RETENTION (urinary retention), BACK PAIN (back pain), NECK PAIN (neck pain), HEADACHE (headache), PYREXIA (fever), NAUSEA (nausea) and VOMITING (vomiting) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Atopic dermatitis, Depression, Upper respiratory infection and Diarrhea.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ACUTE DISSEMINATED ENCEPHALOMYELITIS (Acute disseminated encephalomyelitis) (seriousness criteria hospitalization and medically significant), URINARY RETENTION (urinary retention) (seriousness criteria hospitalization and medically significant), BACK PAIN (back pain) (seriousness criterion hospitalization), NECK PAIN (neck pain) (seriousness criterion hospitalization), HEADACHE (headache) (seriousness criterion hospitalization), PYREXIA (fever) (seriousness criterion hospitalization), NAUSEA (nausea) (seriousness criterion hospitalization) and VOMITING (vomiting) (seriousness criterion hospitalization). The patient was treated with METHYLPREDNISOLONE at an unspecified dose and frequency. At the time of the report, ACUTE DISSEMINATED ENCEPHALOMYELITIS (Acute disseminated encephalomyelitis), URINARY RETENTION (urinary retention), BACK PAIN (back pain), NECK PAIN (neck pain), HEADACHE (headache), PYREXIA (fever), NAUSEA (nausea) and VOMITING (vomiting) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: high (High) Fever 37.5 degree Celsius. On an unknown date, Magnetic resonance imaging head: abnormal (abnormal) Showed distinctive for ADEM wide spread demyelinating lesions. On an unknown date, Magnetic resonance imaging spinal: abnormal (abnormal) Showed distinctive for ADEM wide spread demyelinating lesions. On an unknown date, Neurological examination: abnormal (abnormal) showed Nuchal rigidity, bilateral Babinski signs with out neurological deficit symptoms.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medical information were reported. Company Comment : Very limited information regarding this event has been provided at this time. Further information has been requested.; Sender's Comments: Very limited information regarding this event has been provided at this time. Further information has been requested.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Urinary retention, Vomiting
Clinical narrative: Acute disseminated encephalomyelitis; urinary retention; back pain; neck pain; headache; fever; nausea; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of ACUTE DISSEMINATED ENCEPHALOMYELITIS (Acute disseminated encephalomyelitis), URINARY RETENTION (urinary retention), BACK PAIN (back pain), NECK PAIN (neck pain), HEADACHE (headache), PYREXIA (fever), NAUSEA (nausea) and VOMITING (vomiting) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Atopic dermatitis, Depression, Upper respiratory infection and Diarrhea.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ACUTE DISSEMINATED ENCEPHALOMYELITIS (Acute disseminated encephalomyelitis) (seriousness criteria hospitalization and medically significant), URINARY RETENTION (urinary retention) (seriousness criteria hospitalization and medically significant), BACK PAIN (back pain) (seriousness criterion hospitalization), NECK PAIN (neck pain) (seriousness criterion hospitalization), HEADACHE (headache) (seriousness criterion hospitalization), PYREXIA (fever) (seriousness criterion hospitalization), NAUSEA (nausea) (seriousness criterion hospitalization) and VOMITING (vomiting) (seriousness criterion hospitalization). The patient was treated with METHYLPREDNISOLONE at an unspecified dose and frequency. At the time of the report, ACUTE DISSEMINATED ENCEPHALOMYELITIS (Acute disseminated encephalomyelitis), URINARY RETENTION (urinary retention), BACK PAIN (back pain), NECK PAIN (neck pain), HEADACHE (headache), PYREXIA (fever), NAUSEA (nausea) and VOMITING (vomiting) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: high (High) Fever 37.5 degree Celsius. On an unknown date, Magnetic resonance imaging head: abnormal (abnormal) Showed distinctive for ADEM wide spread demyelinating lesions. On an unknown date, Magnetic resonance imaging spinal: abnormal (abnormal) Showed distinctive for ADEM wide spread demyelinating lesions. On an unknown date, Neurological examination: abnormal (abnormal) showed Nuchal rigidity, bilateral Babinski signs with out neurological deficit symptoms.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medical information were reported. Company Comment : Very limited information regarding this event has been provided at this time. Further information has been requested.; Sender's Comments: Very limited information regarding this event has been provided at this time. Further information has been requested.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Myalgia, Nasopharyngitis
Clinical narrative: Shaking from cold; shaking from cold and it is not cold at all; Soreness at injection site; Pyrexia; Fatigue; Severe chills; Arm looked swollen a good size at injection site; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (Shaking from cold), NASOPHARYNGITIS (shaking from cold and it is not cold at all), VACCINATION SITE REACTION (Soreness at injection site), PYREXIA (Pyrexia) and MYALGIA (Sore arm) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 063E21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Sep-2021 at 12:10 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Sep-2021, the patient experienced MYALGIA (Sore arm) and VACCINATION SITE SWELLING (Arm looked swollen a good size at injection site). On an unknown date, the patient experienced TREMOR (Shaking from cold), NASOPHARYNGITIS (shaking from cold and it is not cold at all), VACCINATION SITE REACTION (Soreness at injection site), PYREXIA (Pyrexia), FATIGUE (Fatigue) and CHILLS (Severe chills). At the time of the report, TREMOR (Shaking from cold), NASOPHARYNGITIS (shaking from cold and it is not cold at all), VACCINATION SITE REACTION (Soreness at injection site), PYREXIA (Pyrexia), MYALGIA (Sore arm), FATIGUE (Fatigue), CHILLS (Severe chills) and VACCINATION SITE SWELLING (Arm looked swollen a good size at injection site) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100.4 (High) 100.4 Fahrenheit.         Concomitant medication included A-fib Medication and cholesterol medication.  Treatment information was not reported   This case was linked to MOD-2021-307229 (Patient Link).
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Tremor, Vaccination site reaction, Vaccination site swelling
Clinical narrative: Shaking from cold; shaking from cold and it is not cold at all; Soreness at injection site; Pyrexia; Fatigue; Severe chills; Arm looked swollen a good size at injection site; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (Shaking from cold), NASOPHARYNGITIS (shaking from cold and it is not cold at all), VACCINATION SITE REACTION (Soreness at injection site), PYREXIA (Pyrexia) and MYALGIA (Sore arm) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 063E21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Sep-2021 at 12:10 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Sep-2021, the patient experienced MYALGIA (Sore arm) and VACCINATION SITE SWELLING (Arm looked swollen a good size at injection site). On an unknown date, the patient experienced TREMOR (Shaking from cold), NASOPHARYNGITIS (shaking from cold and it is not cold at all), VACCINATION SITE REACTION (Soreness at injection site), PYREXIA (Pyrexia), FATIGUE (Fatigue) and CHILLS (Severe chills). At the time of the report, TREMOR (Shaking from cold), NASOPHARYNGITIS (shaking from cold and it is not cold at all), VACCINATION SITE REACTION (Soreness at injection site), PYREXIA (Pyrexia), MYALGIA (Sore arm), FATIGUE (Fatigue), CHILLS (Severe chills) and VACCINATION SITE SWELLING (Arm looked swollen a good size at injection site) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100.4 (High) 100.4 Fahrenheit.         Concomitant medication included A-fib Medication and cholesterol medication.  Treatment information was not reported   This case was linked to MOD-2021-307229 (Patient Link).
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary mass, Dizziness, Pyrexia, Tachycardia
Clinical narrative: Axillary area is swollen; Almost fainted; Fever; Fast heart beat; This spontaneous case was reported by an other health care professional and describes the occurrence of TACHYCARDIA (Fast heart beat), AXILLARY MASS (Axillary area is swollen), DIZZINESS (Almost fainted) and PYREXIA (Fever) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     Concurrent medical conditions included Cancer and Penicillin allergy.    On 02-Sep-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Sep-2021, the patient experienced TACHYCARDIA (Fast heart beat) and PYREXIA (Fever). On 03-Sep-2021, the patient experienced AXILLARY MASS (Axillary area is swollen) and DIZZINESS (Almost fainted). At the time of the report, TACHYCARDIA (Fast heart beat), AXILLARY MASS (Axillary area is swollen), DIZZINESS (Almost fainted) and PYREXIA (Fever) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. The patient took OTC pain medication.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pain, Peripheral swelling, Vaccination site pain
Clinical narrative: arm slightly swollen; soreness in the injection site; pain; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (arm slightly swollen), VACCINATION SITE PAIN (soreness in the injection site), PAIN (pain) and FATIGUE (fatigue) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     Concomitant products included HIV medication, Blood thinner medication, Chronic pancreatitis medication and Blood pressure medication for an unknown indication.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (arm slightly swollen), VACCINATION SITE PAIN (soreness in the injection site), PAIN (pain) and FATIGUE (fatigue). At the time of the report, PERIPHERAL SWELLING (arm slightly swollen), VACCINATION SITE PAIN (soreness in the injection site), PAIN (pain) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided.   This case was linked to MOD-2021-308689 (Patient Link).
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Feeling abnormal, Gait disturbance, Myalgia
Clinical narrative: multiple muscular joint pain; back pain; really bad muscle pain; legs giving problems when walking,it's the worse now in toes, fingers, and whole left side; its really bad today; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (multiple muscular joint pain), BACK PAIN (back pain), MYALGIA (really bad muscle pain), GAIT DISTURBANCE (legs giving problems when walking,it's the worse now in toes, fingers, and whole left side) and FEELING ABNORMAL (its really bad today) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036A21A and 021B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (multiple muscular joint pain), BACK PAIN (back pain), MYALGIA (really bad muscle pain), GAIT DISTURBANCE (legs giving problems when walking,it's the worse now in toes, fingers, and whole left side) and FEELING ABNORMAL (its really bad today). The patient was treated with TIZANIDINE at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, ARTHRALGIA (multiple muscular joint pain), BACK PAIN (back pain), MYALGIA (really bad muscle pain), GAIT DISTURBANCE (legs giving problems when walking,it's the worse now in toes, fingers, and whole left side) and FEELING ABNORMAL (its really bad today) outcome was unknown.            No Concomitant informations were reported.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Dysstasia, Feeling abnormal, Hypoaesthesia, Paraesthesia
Clinical narrative: experience numbness around the right ankle/It feels numb; tingling around the right ankle/feels like needles and pins; feels like sometimes something moving in there/feeling is not constant; feel it when they stand up; pain/hurts a little around the ankle; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (experience numbness around the right ankle/It feels numb), PARAESTHESIA (tingling around the right ankle/feels like needles and pins), FEELING ABNORMAL (feels like sometimes something moving in there/feeling is not constant), DYSSTASIA (feel it when they stand up) and ARTHRALGIA (pain/hurts a little around the ankle) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058A21A) for COVID-19 vaccination.     Concomitant products included PANTOPRAZOLE for Acid reflux (esophageal), TEMAZEPAM and SUMATRIPTAN for an unknown indication.   On 26-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (experience numbness around the right ankle/It feels numb), PARAESTHESIA (tingling around the right ankle/feels like needles and pins), FEELING ABNORMAL (feels like sometimes something moving in there/feeling is not constant), DYSSTASIA (feel it when they stand up) and ARTHRALGIA (pain/hurts a little around the ankle). At the time of the report, HYPOAESTHESIA (experience numbness around the right ankle/It feels numb), PARAESTHESIA (tingling around the right ankle/feels like needles and pins), FEELING ABNORMAL (feels like sometimes something moving in there/feeling is not constant), DYSSTASIA (feel it when they stand up) and ARTHRALGIA (pain/hurts a little around the ankle) outcome was unknown.            No treatment medications were reported.   This case was linked to MOD-2021-269806 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: inadvertently administered Moderna's COVID-19 vaccine to patients outside the product's labeled storage conditions.; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (inadvertently administered Moderna's COVID-19 vaccine to patients outside the product's labeled storage conditions.) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (inadvertently administered Moderna's COVID-19 vaccine to patients outside the product's labeled storage conditions.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (inadvertently administered Moderna's COVID-19 vaccine to patients outside the product's labeled storage conditions.) had resolved. Not Provided          No concomitant medications were provided.  No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Product contamination physical
Clinical narrative: 9 doses administered out of a vial that has a particulate; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT CONTAMINATION PHYSICAL (9 doses administered out of a vial that has a particulate) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002F21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT CONTAMINATION PHYSICAL (9 doses administered out of a vial that has a particulate). At the time of the report, PRODUCT CONTAMINATION PHYSICAL (9 doses administered out of a vial that has a particulate) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medication was reported.  No treatment medications were reported
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Incomplete vaccination schedule since march/No second dose since march; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Incomplete vaccination schedule since march/No second dose since march) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Incomplete vaccination schedule since march/No second dose since march). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Incomplete vaccination schedule since march/No second dose since march) had resolved.            Treatment medication was  not reported. Relevant concomitant medications were not provided by the reporter.   Reporter did not allow further contact
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Inappropriate schedule of product administration
Clinical narrative: sharp needle pain in chest with standing up and laying down; 1st dose of the Moderna vaccine on 16-Aug-2021 & 2nd dose of the Moderna vaccine on 03-Sep-2021; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (sharp needle pain in chest with standing up and laying down) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose of the Moderna vaccine on 16-Aug-2021 & 2nd dose of the Moderna vaccine on 03-Sep-2021) in a 29-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 049E21A and 033D21A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Sep-2021, the patient experienced CHEST PAIN (sharp needle pain in chest with standing up and laying down) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose of the Moderna vaccine on 16-Aug-2021 & 2nd dose of the Moderna vaccine on 03-Sep-2021). The patient was treated with PARACETAMOL (TYLENOL) for Chest pain, at an unspecified dose and frequency and NAPROXEN SODIUM (ALEVE) for Chest pain, at an unspecified dose and frequency. On 03-Sep-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose of the Moderna vaccine on 16-Aug-2021 & 2nd dose of the Moderna vaccine on 03-Sep-2021) had resolved. At the time of the report, CHEST PAIN (sharp needle pain in chest with standing up and laying down) outcome was unknown.            Concomitant product use was not provided by the reporter
Sex: U
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: Still sick a week after I got the first dose; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Still sick a week after I got the first dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (Still sick a week after I got the first dose). At the time of the report, ILLNESS (Still sick a week after I got the first dose) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Relevant concomitant medications were not reported.  The treatment information was  not provided.
Age: 50.0
Sex: U
Vaccine: COVID19
Symptoms: Blister, Pruritus
Clinical narrative: Blister on stomach; It was itchy.; This spontaneous case was reported by a consumer and describes the occurrence of BLISTER (Blister on stomach) and PRURITUS (It was itchy.) in a 50-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026D21A) for COVID-19 vaccination.     Concomitant products included INSULIN for an unknown indication.    On 01-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Sep-2021, the patient experienced BLISTER (Blister on stomach) and PRURITUS (It was itchy.). At the time of the report, BLISTER (Blister on stomach) and PRURITUS (It was itchy.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medication was reported by patient.
Sex: U
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Each day I'm more fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Each day I'm more fatigue) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Aug-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (Each day I'm more fatigue). At the time of the report, FATIGUE (Each day I'm more fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was given by reporter.  No treatment medication was given by reporter
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: 2nd dose >35 days; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (2nd dose >35 days) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (2nd dose >35 days). At the time of the report, PRODUCT DOSE OMISSION ISSUE (2nd dose >35 days) outcome was unknown.            No concomitant medication was reported. No treatment medication was reported. Patient stated that patient was disabled and wanted to be vaccinated with the second dose. Patient's daughter got sick, and then Patient grandchild got sick and had not been provided with the second dose due to personal problems   Most recent FOLLOW-UP information incorporated above includes: On 06-Sep-2021: Follow-up document received contains no new information(NNI) On 06-Sep-2021: Follow-up document received contains no new information(NNI)
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dehydration, Diarrhoea, Myalgia, Pyrexia
Clinical narrative: Became dehydrated; fever; chills; body aches; Diarrhea; Fever; Chills; Body aches; This spontaneous case was reported by a patient family member or friend and describes the occurrence of DIARRHEA (Diarrhea), DEHYDRATION (Became dehydrated), PYREXIA (Fever), CHILLS (Chills) and MYALGIA (Body aches) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 27-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Aug-2021, the patient experienced PYREXIA (Fever), CHILLS (Chills) and MYALGIA (Body aches). On 03-Sep-2021, the patient experienced DIARRHEA (Diarrhea), PYREXIA (fever), CHILLS (chills) and MYALGIA (body aches). On an unknown date, the patient experienced DEHYDRATION (Became dehydrated). At the time of the report, DIARRHEA (Diarrhea), DEHYDRATION (Became dehydrated), PYREXIA (fever), CHILLS (chills) and MYALGIA (body aches) outcome was unknown and PYREXIA (Fever), CHILLS (Chills) and MYALGIA (Body aches) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not provided.  Treatment information include over the counter medicine for Diarrhea.  On 27-Aug-2021 in the evening, the patient had typical side effects of fever, chills, body aches.  Patient's side effects improved, however on 03-Sep-2021 about a week from original vaccination date patient had diarrhea.  Then the fever, chills and body aches also returned on 03-Sep-2021. On 05-Sep-2021, the patient went to the emergency room (ER). They performed several tests and the tests came back normal. The ER doctor concluded that patient had become dehydrated because of her side effects.  ER gave patient different medicines to stabilize her.